Leverage has risen sharply as equity eroded from $3.3B to $1.4B, pushing debt-to-equity to 1.71, while total debt stayed near $2.3B and goodwill write-downs of $1.3B have left the remaining $1.1B at 79% of equity, limiting further impairment capacity.
DENTSPLY SIRONA Inc. (XRAY) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 1.98B | 2.02B | 1.75B | 1.97B | 1.89B | 1.85B | 1.8B | 2B | 1.89B | 2B | 1.88B | 1.2B | 1.21B | 1.14B | 1.11B | 1.01B | 1.32B | 1.22B | 949.86M | 982.02M | 718.19M | 1.03B | 1.06B | 727.45M | 541M | 484.24M | 325.45M | 314.7M | 322.5M | 277M | 256.7M |
| Cash & Short-Term Investments | 195M | 326M | 272M | 334M | 365M | 339M | 438M | 405M | 309.6M | 320.6M | 383.9M | 284.6M | 151.64M | 74.95M | 80.13M | 77.13M | 540.04M | 450.38M | 204.25M | 316.32M | 65.14M | 434.52M | 506.37M | 163.75M | 25.65M | 33.71M | 15.43M | 7.3M | 8.7M | 9.8M | 5.6M |
| Cash Only | 195M | 326M | 272M | 334M | 365M | 339M | 438M | 405M | 309.6M | 320.6M | 383.9M | 284.6M | 151.64M | 74.95M | 80.13M | 77.13M | 540.04M | 450.35M | 203.99M | 169.38M | 65.06M | 434.52M | 506.37M | 163.75M | 25.65M | 33.71M | 15.43M | 7.3M | 8.7M | 9.8M | 5.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37K | 258K | 146.94M | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 605M | 688M | 606M | 756M | 685M | 803M | 706M | 828M | 701.9M | 746.2M | 636M | 399.9M | 426.6M | 472.8M | 442.41M | 427.71M | 344.8M | 348.68M | 319.26M | 307.62M | 290.79M | 254.82M | 238.87M | 241.38M | 221.26M | 191.53M | 133.64M | 127.91M | 134.2M | 114.4M | 102M |
| Days Sales Outstanding | 64.7 | 68.24 | 58.32 | 69.59 | 63.75 | 69.27 | 77.18 | 75.14 | 64.27 | 68.2 | 61.98 | 54.58 | 53.28 | 58.48 | 55.14 | 61.52 | 56.66 | 58.92 | 53.12 | 55.87 | 58.62 | 54.23 | 51.46 | 56.09 | 53.35 | 61.92 | 54.82 | 56.19 | 61.61 | 57.93 | 56.7 |
| Inventory | 707M | 642M | 564M | 624M | 627M | 515M | 476M | 562M | 598.9M | 623.1M | 517.1M | 340.4M | 387.1M | 438.56M | 402.94M | 361.76M | 308.74M | 291.64M | 306.13M | 258.03M | 232.44M | 208.18M | 213.71M | 205.59M | 214.49M | 197.45M | 133.3M | 135.5M | 139.2M | 124.7M | 125.4M |
| Days Inventory Outstanding | 137.88 | 127.35 | 112.19 | 121.21 | 127.5 | 99.77 | 103.23 | 110.4 | 113.94 | 126.01 | 108.2 | 107.38 | 106.81 | 116.56 | 107.19 | 104.44 | 103.3 | 101.51 | 107.25 | 97.19 | 96.25 | 89.8 | 92.02 | 94.07 | 100.26 | 128.83 | 126.43 | 137.65 | 148.91 | 142.41 | 150.66 |
| Other Current Assets | 471M | 367M | 153M | 146M | 88M | 84M | 67M | 84M | 172.8M | 120.7M | 122.9M | 132.9M | 150.08M | 121.36M | 130.73M | 113.41M | 0 | -37K | 0 | 0 | 0 | -3.04M | 0 | 28.26M | 0 | 61.55M | 43.07M | 44M | 40.4M | 28.1M | 23.7M |
| Total Non-Current Assets | 3.21B | 3.41B | 4.01B | 5.4B | 5.75B | 7.39B | 7.55B | 6.6B | 6.8B | 8.38B | 9.77B | 3.21B | 3.44B | 3.93B | 3.86B | 3.74B | 1.94B | 1.87B | 1.88B | 1.69B | 1.46B | 1.38B | 1.74B | 1.72B | 1.55B | 1.31B | 541.16M | 544.9M | 572.8M | 497.4M | 411M |
| Property, Plant & Equipment | 971M | 1B | 902M | 978M | 961M | 971M | 967M | 961M | 870.6M | 876M | 799.8M | 558.8M | 588.85M | 637.17M | 614.71M | 591.45M | 423.11M | 439.62M | 432.28M | 371.41M | 329.62M | 316.22M | 407.53M | 376.21M | 313.18M | 240.89M | 181.34M | 180.5M | 159M | 147.1M | 141.5M |
| Fixed Asset Turnover | 3.63x | 3.68x | 4.21x | 4.05x | 4.08x | 4.36x | 3.45x | 4.19x | 4.58x | 4.56x | 4.68x | 4.79x | 4.96x | 4.63x | 4.76x | 4.29x | 5.25x | 4.91x | 5.07x | 5.41x | 5.49x | 5.42x | 4.16x | 4.18x | 4.83x | 4.69x | 4.91x | 4.60x | 5.00x | 4.90x | 4.64x |
| Goodwill | 1.14B | 1.15B | 1.6B | 2.44B | 2.69B | 3.98B | 3.99B | 3.4B | 3.43B | 4.52B | 5.95B | 1.99B | 2.09B | 2.28B | 2.21B | 2.19B | 1.3B | 1.31B | 1.28B | 1.13B | 995.38M | 0 | 0 | 0 | 0 | 763.27M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 815M | 974M | 1.21B | 1.71B | 1.9B | 2.32B | 2.5B | 2.18B | 2.42B | 2.83B | 2.96B | 600.7M | 670.84M | 795.32M | 830.64M | 791.1M | 78.74M | 89.09M | 103.72M | 76.17M | 67.65M | 1B | 1.25B | 1.21B | 1.13B | 248.89M | 344.75M | 349.4M | 346.1M | 103.5M | 256.2M |
| Long-Term Investments | 5M | 0 | 23M | 0 | 0 | 0 | 0 | 0 | -552.8M | -718M | -848.6M | -160.3M | -165.55M | -238.39M | -232.64M | -249.82M | -72.49M | -72.52M | -69.05M | -60.55M | -53.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 290M | 284M | 278M | 48M | 198M | 121M | 95M | 69M | 76.8M | 156.2M | 64.1M | 59.1M | 94.27M | 220.15M | 204.9M | 169.89M | 138M | 28.84M | 67.52M | 118.55M | 70.51M | 59.24M | 79.86M | 132.19M | 98.35M | 60.86M | 15.07M | 15M | 67.7M | 246.8M | 13.3M |
| Total Assets | 5.19B | 5.43B | 5.75B | 7.37B | 7.64B | 9.24B | 9.35B | 8.6B | 8.69B | 10.38B | 11.66B | 4.4B | 4.65B | 5.08B | 4.97B | 4.76B | 3.26B | 3.09B | 2.83B | 2.68B | 2.18B | 2.41B | 2.8B | 2.45B | 2.09B | 1.8B | 866.62M | 859.6M | 895.3M | 774.4M | 667.7M |
| Asset Turnover | 0.68x | 0.68x | 0.66x | 0.54x | 0.51x | 0.46x | 0.36x | 0.47x | 0.46x | 0.38x | 0.32x | 0.61x | 0.63x | 0.58x | 0.59x | 0.53x | 0.68x | 0.70x | 0.78x | 0.75x | 0.83x | 0.71x | 0.61x | 0.64x | 0.73x | 0.63x | 1.03x | 0.97x | 0.89x | 0.93x | 0.98x |
| Asset Growth % | -41.65% | -5.63% | -21.94% | -3.57% | -17.27% | -1.19% | 8.68% | -0.97% | -16.31% | -10.95% | 164.74% | -5.32% | -8.42% | 2.13% | 4.56% | 45.96% | 5.51% | 9.1% | 5.79% | 22.66% | -9.39% | -13.97% | 14.42% | 17.18% | 16.07% | 107.49% | 0.82% | -3.99% | 15.61% | 15.98% | 11.71% |
| Total Current Liabilities | 1.22B | 1.34B | 1.59B | 1.43B | 1.17B | 1.26B | 1.37B | 995M | 1.01B | 946.6M | 771M | 476M | 653.59M | 796.4M | 927.78M | 724.07M | 360.09M | 444.56M | 359.96M | 312.41M | 311.43M | 741.23M | 404.61M | 337.68M | 365.75M | 358.52M | 168.14M | 176.2M | 194.4M | 169.3M | 143.2M |
| Accounts Payable | 238M | 300M | 241M | 305M | 279M | 262M | 302M | 308M | 283.9M | 284.4M | 223M | 133.6M | 132.6M | 132.79M | 165.29M | 149.12M | 114.48M | 100.85M | 104.33M | 82.32M | 79.95M | 82.32M | 91.58M | 86.34M | 66.63M | 69.9M | 45.76M | 44.61M | 42.7M | 38.9M | 33.7M |
| Days Payables Outstanding | 54.52 | 59.51 | 47.94 | 59.25 | 56.73 | 50.76 | 65.5 | 60.51 | 54.01 | 57.51 | 46.66 | 42.14 | 36.59 | 35.29 | 43.97 | 43.05 | 38.3 | 35.1 | 36.55 | 31.01 | 33.11 | 35.51 | 39.43 | 39.5 | 31.14 | 45.61 | 43.4 | 45.32 | 45.68 | 44.43 | 40.49 |
| Short-Term Debt | 215M | 360M | 549M | 322M | 118M | 182M | 299M | 2M | 92.4M | 30.1M | 21.1M | 12.1M | 112.83M | 309.86M | 298.96M | 276.7M | 7.75M | 82.17M | 25.8M | 1.24M | 3M | 412.21M | 72.88M | 21.97M | 4.55M | 7.63M | 794K | 20.2M | 16.3M | 24M | 26.7M |
| Deferred Revenue (Current) | 143M | 74M | 95M | 91M | 84M | 68M | 53M | 29M | 29.3M | 8.9M | 14.1M | 2.2M | 3.48M | 4.92M | 5.51M | 0 | 0 | -110.5M | 0 | 189.41M | 181.2M | 159.85M | 179.76M | 172.68M | 190.78M | 194.36M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 58M | 408M | 64M | 169M | 182M | 212M | 166M | 128M | 339.1M | 353.3M | 260.1M | 166.9M | 8.28M | 197.58M | 287.6M | 163.48M | 146.32M | 0 | 108.29M | 0 | 114.86M | 105.55M | 122.03M | 56.69M | 103.79M | 86.62M | 121.58M | 111.39M | 135.4M | 106.4M | 82.8M |
| Current Ratio | 1.63x | 1.51x | 1.10x | 1.38x | 1.62x | 1.47x | 1.31x | 2.01x | 1.86x | 2.12x | 2.44x | 2.51x | 1.85x | 1.44x | 1.20x | 1.40x | 3.65x | 2.74x | 2.64x | 3.14x | 2.31x | 1.39x | 2.61x | 2.15x | 1.48x | 1.35x | 1.94x | 1.79x | 1.66x | 1.64x | 1.79x |
| Quick Ratio | 1.04x | 1.03x | 0.74x | 0.95x | 1.08x | 1.06x | 0.96x | 1.45x | 1.27x | 1.46x | 1.77x | 1.80x | 1.25x | 0.89x | 0.76x | 0.90x | 2.79x | 2.08x | 1.79x | 2.32x | 1.56x | 1.11x | 2.08x | 1.55x | 0.89x | 0.80x | 1.14x | 1.02x | 0.94x | 0.90x | 0.92x |
| Cash Conversion Cycle | 148.06 | 136.08 | 122.56 | 131.56 | 134.51 | 118.29 | 114.91 | 125.04 | 124.2 | 136.7 | 123.52 | 119.81 | 123.5 | 139.75 | 118.36 | 122.91 | 121.66 | 125.33 | 123.82 | 122.05 | 121.77 | 108.52 | 104.05 | 110.65 | 122.47 | 145.14 | 137.85 | 148.52 | 164.84 | 155.92 | 166.87 |
| Total Non-Current Liabilities | 2.62B | 2.75B | 2.22B | 2.65B | 2.66B | 2.98B | 3.04B | 2.51B | 2.54B | 2.79B | 2.76B | 1.59B | 1.67B | 1.7B | 1.8B | 2.15B | 987.95M | 736.42M | 882.72M | 846.76M | 595.86M | 424.33M | 948.97M | 985.42M | 884.1M | 829.68M | 173.55M | 212M | 284.4M | 177.2M | 154.6M |
| Long-Term Debt | 1.99B | 2.02B | 1.59B | 1.8B | 1.83B | 1.91B | 1.98B | 1.43B | 1.56B | 1.61B | 1.51B | 1.14B | 1.15B | 1.17B | 1.22B | 1.49B | 604.01M | 387.15M | 423.68M | 482.06M | 367.16M | 270.1M | 779.94M | 790.2M | 769.82M | 723.52M | 109.5M | 145.3M | 217.5M | 105.5M | 75.1M |
| Capital Lease Obligations | 363M | 93M | 91M | 125M | 149M | 149M | 130M | 120M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 323M | 86M | 129M | 228M | 287M | 391M | 381M | 480M | 552.8M | 718M | 848.6M | 160.3M | 165.55M | 238.39M | 232.64M | 249.82M | 72.49M | 72.52M | 69.05M | 60.55M | 53.19M | 42.91M | 58.2M | 51.24M | 27.04M | 32.53M | 16.82M | 20.2M | 18.8M | 27.6M | 30M |
| Other Non-Current Liabilities | 443M | 457M | 415M | 502M | 399M | 528M | 554M | 480M | 975.8M | 1.18B | 1.25B | 446.5M | 521.59M | 537.49M | 573.04M | 657.16M | 383.93M | 349.27M | 389.99M | 364.69M | 175.51M | 111.31M | 110.83M | 143.97M | 87.24M | 73.63M | 47.23M | 46.5M | 48.1M | 44.1M | 49.5M |
| Total Liabilities | 3.84B | 4.09B | 3.81B | 4.08B | 3.83B | 4.24B | 4.42B | 3.51B | 3.55B | 3.74B | 3.53B | 2.06B | 2.33B | 2.5B | 2.72B | 2.87B | 1.35B | 1.18B | 1.24B | 1.16B | 907.29M | 1.17B | 1.35B | 1.32B | 1.25B | 1.19B | 341.68M | 388.2M | 478.8M | 346.5M | 297.8M |
| Total Debt | 2.29B | 2.47B | 2.27B | 2.3B | 2.15B | 2.29B | 2.46B | 1.6B | 1.66B | 1.61B | 1.51B | 1.14B | 1.15B | 1.17B | 1.22B | 1.49B | 604.01M | 387.15M | 449.47M | 483.31M | 370.16M | 682.32M | 852.82M | 812.17M | 774.37M | 731.16M | 110.29M | 165.5M | 233.8M | 129.5M | 101.8M |
| Net Debt | 2.09B | 2.14B | 2B | 1.97B | 1.78B | 1.96B | 2.02B | 1.19B | 1.35B | 1.29B | 1.13B | 856.4M | 1B | 1.09B | 1.14B | 1.41B | 63.98M | -63.2M | 245.48M | 313.92M | 305.09M | 247.79M | 346.45M | 648.42M | 748.72M | 697.45M | 94.86M | 158.2M | 225.1M | 119.7M | 96.2M |
| Debt / Equity | 1.69x | 1.84x | 1.17x | 0.70x | 0.56x | 0.46x | 0.50x | 0.31x | 0.32x | 0.24x | 0.19x | 0.49x | 0.50x | 0.45x | 0.54x | 0.79x | 0.32x | 0.20x | 0.28x | 0.32x | 0.29x | 0.55x | 0.59x | 0.72x | 0.92x | 1.20x | 0.21x | 0.35x | 0.56x | 0.30x | 0.28x |
| Debt / EBITDA | 3.03x | 4.09x | - | 8.91x | - | 2.40x | 7.42x | 2.37x | - | - | 2.08x | 2.29x | 2.01x | 2.13x | 2.39x | 3.86x | 1.35x | 0.87x | 1.03x | 1.19x | 1.02x | 5.53x | 2.48x | 2.59x | 2.58x | 3.14x | 0.54x | 0.87x | 1.31x | 0.79x | 0.69x |
| Net Debt / EBITDA | 2.77x | 3.55x | - | 7.62x | - | 2.05x | 6.09x | 1.77x | - | - | 1.55x | 1.72x | 1.74x | 1.99x | 2.23x | 3.66x | 0.14x | -0.14x | 0.56x | 0.77x | 0.84x | 2.01x | 1.01x | 2.07x | 2.49x | 3.00x | 0.46x | 0.84x | 1.26x | 0.73x | 0.65x |
| Interest Coverage | 0.02x | -4.52x | -12.57x | -1.16x | -15.23x | 9.93x | -0.06x | 12.41x | -24.69x | -40.93x | 13.28x | 6.90x | 9.51x | 8.40x | 6.82x | 6.72x | 14.89x | 21.61x | 11.93x | 31.88x | 30.19x | 17.20x | 12.04x | 10.42x | 6.65x | - | 16.14x | 17.60x | 0.90x | 16.36x | 19.92x |
| Total Equity | 1.35B | 1.34B | 1.94B | 3.29B | 3.81B | 5B | 4.93B | 5.09B | 5.13B | 6.64B | 8.13B | 2.34B | 2.32B | 2.58B | 2.25B | 1.88B | 1.91B | 1.91B | 1.59B | 1.52B | 1.27B | 1.24B | 1.44B | 1.12B | 837.19M | 609.96M | 524.93M | 471.4M | 416.5M | 427.9M | 369.9M |
| Equity Growth % | -104.91% | -31.03% | -41.01% | -13.59% | -23.71% | 1.26% | -3.14% | -0.74% | -22.71% | -18.27% | 247.35% | 0.74% | -9.92% | 14.61% | 19.39% | -1.35% | 0.15% | 20.11% | 4.7% | 19.02% | 2.6% | -14.04% | 28.69% | 34.08% | 37.25% | 16.2% | 11.36% | 13.18% | -2.66% | 15.68% | 15.85% |
| Book Value per Share | 6.80 | 6.72 | 9.56 | 15.54 | 17.69 | 22.69 | 22.51 | 22.70 | 22.88 | 28.95 | 36.67 | 16.42 | 16.10 | 17.78 | 15.63 | 13.13 | 13.08 | 12.70 | 10.47 | 9.80 | 8.05 | 7.66 | 8.81 | 6.96 | 5.23 | 3.86 | 3.34 | 2.97 | 2.59 | 2.63 | 2.29 |
| Total Shareholders' Equity | 1.35B | 1.34B | 1.94B | 3.29B | 3.81B | 5B | 4.93B | 5.09B | 5.12B | 6.63B | 8.11B | 2.34B | 2.32B | 2.54B | 2.21B | 1.85B | 1.84B | 1.83B | 1.59B | 1.52B | 1.27B | 1.24B | 1.44B | 1.12B | 835.93M | 609.52M | 520.37M | 468.9M | 413.8M | 423.9M | 365.6M |
| Common Stock | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 2.6M | 2.6M | 2.6M | 1.6M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 814K | 814K | 814K | 814K | 814K | 814K | 543K | 500K | 0 | 0 | 0 |
| Retained Earnings | -1.54B | -1.56B | -835M | 205M | 456M | 1.51B | 1.2B | 1.4B | 1.23B | 2.32B | 3.95B | 3.59B | 3.38B | 3.1B | 2.82B | 2.54B | 2.32B | 2.08B | 1.84B | 1.58B | 1.35B | 1.15B | 1.13B | 889.6M | 730.97M | 597.41M | 490.17M | 402.4M | 324.7M | 301.1M | 237.3M |
| Treasury Stock | -3.08B | -3.1B | -3.14B | -2.92B | -2.65B | -2.54B | -2.41B | -2.3B | -2.15B | -1.96B | -1.65B | -898.4M | -841.6M | -748.51M | -713.74M | -727.98M | -711.65M | -532.02M | -479.63M | -387.11M | -328.18M | -138.15M | -36.48M | -39.84M | -52.48M | -60.82M | -68M | -35.92M | 0 | 0 | 0 |
| Accumulated OCI | -647M | -639M | -730M | -636M | -628M | -592M | -464M | -600M | -478.7M | -291M | -705.7M | -594M | -441.14M | -69.06M | -144.2M | -190.97M | 24.16M | 83.54M | 39.61M | 145.82M | 79.91M | 56.45M | 164.1M | 104.54M | -275K | -80.81M | -54.23M | -49.7M | -80.2M | -65M | -56.3M |
| Minority Interest | -1M | 1M | 1M | 1M | 1M | 1M | 3M | 2M | 11.9M | 11.6M | 11.6M | 1.4M | 919K | 42.92M | 40.74M | 36.07M | 70.53M | 74.85M | 0 | 296K | 222K | 188K | 600K | 418K | 1.26M | 437K | 4.56M | 2.5M | 2.7M | 4M | 4.3M |
Quick answers to the most common questions about buying XRAY stock.
As of 2025, DENTSPLY SIRONA Inc. (XRAY) had total assets of $5.43B including $2.02B in current assets.
DENTSPLY SIRONA Inc. (XRAY) carries total debt of $2.47B, offset by $326.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
DENTSPLY SIRONA Inc. (XRAY) has total shareholders' equity (book value) of $1.34B ($6.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.
DENTSPLY SIRONA Inc. (XRAY) reported a current ratio of 1.51x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment and negative retained earnings
Metrics are mathematically derived from official filings.
Balance Sheet Shrinking Amidst Restructuring
Total assets contracted from $7.1B in 2024Q1 to $5.2B in 2026Q2, a 27% decline, while equity fell from $3.3B to $1.4B, reflecting persistent losses and asset write-downs.
The balance sheet is clearly contracting, with total assets down $1.9B over the period. The decline is driven by a combination of goodwill impairments (goodwill fell from $2.4B to $1.1B) and accumulated losses, as retained earnings turned deeply negative. This suggests the company is in a restructuring phase, shedding assets and absorbing charges, which may indicate a lower future earnings base.
Leverage Rising as Equity Erodes
Debt-to-equity climbed from 0.68 in 2024Q1 to 1.71 in 2026Q2, while total debt remained near $2.3B, indicating leverage is rising due to equity erosion rather than new borrowing.
Total debt has been relatively stable around $2.2-2.5B, but the D/E ratio has more than doubled because equity has been cut in half. This suggests the company is not taking on new debt but is becoming more leveraged as losses reduce the equity base. The debt load appears manageable in absolute terms, but the trend is concerning if losses persist, as it could strain future cash flows and refinancing capacity.
Asset Base Shifting Away from Intangibles
Goodwill fell from $2.4B to $1.1B over ten quarters, while PPE remained stable near $1B, indicating a shift from intangible-heavy to more tangible asset mix, reducing impairment risk.
The significant reduction in goodwill suggests the company has taken large impairment charges, likely related to prior acquisitions. This reduces the risk of future goodwill write-downs but also indicates that the company's growth through acquisitions has not generated the expected returns. The stable PPE suggests ongoing investment in fixed assets, but the overall asset base is shrinking, which may limit future revenue-generating capacity.
Equity Quality Deteriorating with Negative Retained Earnings
Retained earnings swung from $190M positive in 2024Q1 to -$1.5B in 2026Q2, while equity fell to $1.4B, indicating the company has consumed its historical earnings buffer.
The negative retained earnings are a red flag, as they indicate cumulative losses have wiped out all prior profits. This reduces the quality of equity, as the remaining equity is likely supported by other components like paid-in capital. The company continues to pay dividends (~$32M per quarter) despite losses, which may be unsustainable and could further erode equity if losses persist.
Liquidity Improving but Cash Buffer Thin
Current ratio improved from 1.10 in 2025Q1 to 1.63 in 2026Q2, but cash remains low at $239M, providing limited cushion against operational shocks.
The current ratio has improved, suggesting better short-term liquidity management, but the absolute cash balance is modest relative to the company's size and debt load. With total debt of $2.3B, the cash position covers only about 10% of debt, which may indicate reliance on operating cash flow or refinancing. The improvement in current ratio is positive, but the thin cash buffer warrants monitoring.
Goodwill Impairment Risk Largely Realized
Goodwill has already been written down by $1.3B over ten quarters, but the remaining $1.1B still represents 79% of equity, leaving limited room for further impairments.
The company has already taken significant goodwill impairments, which have contributed to the negative retained earnings. However, the remaining goodwill is still substantial relative to equity, meaning any further impairment could severely impact the already strained equity base. Investors should monitor the carrying value of goodwill against the company's market performance, as further write-downs could push equity into negative territory.